Immunohistochemistry for Burkitt lymphoma panel CD20, CD10, BCL-6, BCL-2, Ki-67
Burkitt lymphoma (BL) is a highly aggressive mature B-cell non-Hodgkin lymphoma characterized by rapid proliferation and a close association with MYC gene rearrangement. It most frequently affects children and young adults but can occur across all age groups. Histologically, BL exhibits a “starry-sky” pattern due to interspersed tangible-body macrophages within sheets of rapidly dividing neoplastic B cells. Immunohistochemistry (IHC) plays a crucial role in the diagnosis and differentiation of BL from other high-grade B-cell lymphomas. The Burkitt lymphoma panel includes CD20, CD10, BCL-6, BCL-2, and Ki-67, which collectively confirm B-cell lineage, germinal center origin, and proliferative activity:
- CD20: A pan–B-cell marker confirming mature B-cell phenotype.
- CD10 and BCL-6: Indicative of germinal center derivation, typical of BL.
- BCL-2: Generally negative in classic BL, aiding distinction from other B-cell lymphomas (e.g., DLBCL, follicular lymphoma).
- Ki-67: Proliferation index typically exceeds 95%, reflecting the tumor’s high mitotic rate.
This panel provides a comprehensive immunophenotypic profile essential for confirming the diagnosis of BL, differentiating it from morphologically similar entities such as DLBCL, and identifying cases of double-hit lymphoma when combined with molecular testing (e.g., MYC, BCL2, and BCL6 rearrangements).
- As an aid in the diagnosis and management of Burkitt lymphoma
- Differentiation diagnosis of Burkitt lymphoma from mantle cell lymphoma and other lymphomas
- Provides prognostic information, as high Ki-67 correlates with aggressive clinical behavior
- Assists in treatment planning, guiding the use of intensive, short-course chemotherapy regimens
Marker Expected Expression Interpretation:
CD20 Positive Confirms mature B-cell lineage.
CD10 Positive Indicates germinal center origin.
BCL-6 Positive Supports germinal center derivation.
BCL-2 Negative Absence supports BL; positivity may indicate alternative diagnosis (e.g., DLBCL).
Ki-67 >95% Extremely high proliferation index, characteristic of BL.
Negative for markers tested
Formalin-fixed paraffin embedded (FFPE) tissue.
FFPE is stable at room temperature for longer.
- Blood Res. 2022 Apr 30;57(S1):55-61. [PMID: 35483927]
- Ir Med J. 1975 May 24;68(10):247-54. [PMID: 1095525]
- N Engl J Med. 2006 Jun 8;354(23):2431-42. [PMID: 16760443]
- Hematol Oncol. 2010 Jun;28(2):53-6. [PMID: 19844983]
- Burkitt Lymphoma. [Updated 2025 Feb 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538148/